Cyclic AMP induces activation of extracellular signal-regulated kinases in HL-60 cells: Role in cAMP-induced differentiation

Leukemia Research

Volumn 27, Issue 1, 2003, Pages 51-56

  Cho, Young Jin ^a   Kim, Ju Young ^a   Jeong, Seong Whan ^a   Lee, Sang Bok ^a   Kim, Ok Nyu ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

B Raf; Cyclic AMP; Differentiation; Extracellular signal regulated kinase; HL 60 cells; Protein kinase A

Indexed keywords

8 BROMO CYCLIC AMP; CD14 ANTIGEN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; RAF PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANTIGENS, CD14; CELL DIFFERENTIATION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; HL-60 CELLS; HUMANS; ISOQUINOLINES; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; SECOND MESSENGER SYSTEMS; SULFONAMIDES; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE;

EID: 0037212008     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00057-7     Document Type: Article

References (21)

1. Nonaka T., Mio M., Doi M., Tasaka K. Histamine-induced differentiation of HL-60 cells. Biochem. Pharmacol. 44:1992;1115-1121.
2. Jiang L., Foster F.M., Ward P., Tasevski V., Luttrell B.M., Conigrave A.D. Extracellular ATP triggers cyclic AMP-dependent differentiation of HL-60 cells. Biochem. Biophys. Res. Commun. 232:1997;626-630.
3. Bang B.E., Ericsen C., Aarbakke J. Effects of cAMP and cGMP elevating agents on HL-60 cell differentiation. Pharmacol. Toxicol. 75:1994;108-112.
4. Chaplinski T.J., Niedel J.E. Cyclic nucleotide-induced maturation of human promyelocytic leukemia cells. J. Clin. Invest. 70:1982;953-964.
5. kip1 in PMA-induced differentiation of HL-60 cells. FEBS Lett. 472:2000;50-52.
6. 3-induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Biochem. Biophys. Res. Commun. 241:1997;419-426.
7. Yen A., Roberson M.S., Varvayanis S., Lee A.T. Retinoic acid-induced mitogen-activated protein (MAP)/extracellular-signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 58:1998;3163-3172.
8. Häfner S., Adler H.S., Mischak H., Janosch P., Heidecker G., Wolfman A.et al. Mechanism of inhibition of Raf-1 by protein kinase A. Mol. Cell. Biol. 14:1994;6696-6703.
9. Vossler M.R., Yao H., York R.D., Pan M.G., Rim C.S., Stork P.J. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell. 89:1997;73-82.
10. de Rooij J., Zwartkruis F.J., Verheijen M.H., Cool R.H., Nijman S.M., Wittinghofer A.et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature. 396:1998;474-477.
11. Kawasaki H., Springett G.M., Mochizuki N., Toki S., Nakaya M., Matsuda M.et al. A family of cAMP-binding proteins that directly activate Rap1. Science. 282:1998;2275-2279.
12. Choi J.W., Cho Y.-J., Cha S.H., Lee K.H., Lee S.B. Distributional patterns of phospholipase C isozymes in heart and brain of spontaneously hypertensive rats. Korean J. Physiol. Pharmacol. 1:1997;385-392.
13. Cho Y.-J., Ahn W.S., Cha S.H., Lee K.H., Kim W.I., Chung M.H. Hydroxyl radical-mediated commitment of HL-60 cells to differentiation: modulation of differentiation process by phospholipase inhibitors. Korean J. Physiol. Pharmacol. 2:1998;369-376.
14. Yamashiro S., Takayama K., Shiku H., Furukawa K. Up-regulation of small GTP-binding proteins smg P21A and ras P21S during TPA-induced differentiation of human leukemia cell lines. Leuk. Res. 17:1993;129-136.
15. Kurachi H., Wada Y., Tsukamoto N., Maeda M., Kubota H., Hattori M.et al. Human SPA-1 gene product selectively expressed in lymphoid tissues is a specific GTPase-activating protein for Rap1 and Rap2. J. Biol. Chem. 272:1997;28081-28088.
16. Scheele J.S., Pilz R.B., von Lintig F.C., Boss G.R. Deficient post-translational processing of Rap1A in variant HL-60 cells. Oncogene. 17:1998;2211-2223.
17. von Lintig F.C., Pilz R.B., Boss G.R. Quantitative determination of Rap1 activation in cyclic nucleotide-treated HL-60 leukemic cells: lack of Rap1 activation in variant cells. Oncogene. 19:2000;4029-4034.
18. Yao H., York R.D., Misra-Press A., Carr D.W., Stork P.J. The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor. J. Biol. Chem. 273:1998;8240-8247.
19. Qiu W., Zhuang S., Lintig F.C., Boss G.R., Pilz R.B. Cell type-specific regulation of B-Raf kinase by cAMP and 14-3-3 proteins. J. Biol. Chem. 275:2000;31921-31929.
20. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular-signal-regulated kinase activation. Cell. 80:1995;179-185.
21. Traverse S., Gomez N., Paterson H., Marshall C., Cohen P. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288:1992;351-355.